IDEXX Laboratories, Inc. (IDXX)

Market Cap	60.81B
Revenue (ttm)	4.17B
Net Income (ttm)	1.03B
Shares Out	79.85M
EPS (ttm)	12.60
PE Ratio	60.57
Forward PE	54.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	359,845
Open	751.75
Previous Close	752.14
Day's Range	750.36 - 769.24
52-Week Range	356.14 - 769.24
Beta	1.69
Analysts	Buy
Price Target	683.89 (-10.2%)
Earnings Date	Nov 3, 2025

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Analyst Summary

According to 9 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price target is $683.89, which is a decrease of -10.20% from the latest price.

Price Target

$683.89

(-10.20% downside)

Analyst Consensus: Buy